Literature DB >> 21087236

From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders.

Nicolas Gaspard1, Pierre Vanderhaeghen.   

Abstract

Embryonic or induced pluripotent stem cells, available in mouse and human, have emerged as powerful tools to address complex questions in neurobiology. This review focuses on major advances relating to brain development and developmental disorders. Stem cells can differentiate into many different neuronal subtypes using in vitro models mimicking relevant in vivo developmental processes, and the underlying molecular and cellular mechanisms. Disease-specific human embryonic stem cells (ESCs) and induced pluripotent stem (iPS) cells are now available and allow for the study in vitro of the pathophysiology of degenerative and neurodevelopmental hereditary and sporadic disorders, including in the near future those of the human cortex. Finally, some recent studies have shown that stem cell-derived neural progenitors and neurons could help to rebuild damaged brain circuitry, opening the possibility of cell therapy.
© The Authors. Journal compilation © Mac Keith Press 2010.

Entities:  

Mesh:

Year:  2010        PMID: 21087236     DOI: 10.1111/j.1469-8749.2010.03827.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  21 in total

Review 1.  Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.

Authors:  Talita Glaser; Angélica Regina Cappellari; Micheli Mainardi Pillat; Isabele Cristiana Iser; Márcia Rosângela Wink; Ana Maria Oliveira Battastini; Henning Ulrich
Journal:  Purinergic Signal       Date:  2011-12-06       Impact factor: 3.765

2.  Human pluripotent stem cell differentiation into authentic striatal projection neurons.

Authors:  Alessia Delli Carri; Marco Onorati; Valentina Castiglioni; Andrea Faedo; Stefano Camnasio; Mauro Toselli; Gerardo Biella; Elena Cattaneo
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

3.  E-cadherin-transfected neural stem cells transplantation for spinal cord injury in rats.

Authors:  Chen Zhang; Feng Tu; Ji-Yin Zhang; Lin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

4.  Report of a workshop on research gaps in the treatment of cerebral palsy.

Authors:  Codrin Lungu; Deborah Hirtz; Diane Damiano; Paul Gross; Jonathan W Mink
Journal:  Neurology       Date:  2016-08-24       Impact factor: 9.910

5.  Duration of culture and sonic hedgehog signaling differentially specify PV versus SST cortical interneuron fates from embryonic stem cells.

Authors:  Jennifer A Tyson; Ethan M Goldberg; Asif M Maroof; Qing Xu; Timothy J Petros; Stewart A Anderson
Journal:  Development       Date:  2015-04-01       Impact factor: 6.868

6.  Rett Syndrome.

Authors:  E E J Smeets; K Pelc; B Dan
Journal:  Mol Syndromol       Date:  2012-04-16

7.  Ethanol alters the balance of Sox2, Oct4, and Nanog expression in distinct subpopulations during differentiation of embryonic stem cells.

Authors:  Joshua W Ogony; Evangelia Malahias; Rajanikanth Vadigepalli; Helen Anni
Journal:  Stem Cells Dev       Date:  2013-04-09       Impact factor: 3.272

8.  Human skin keratinocytes can be reprogrammed to express neuronal genes and proteins after a single treatment with decitabine.

Authors:  Jackie R Bickenbach; Ann Tomanek-Chalkley; Susan Wiechert; Michael C Winter
Journal:  Biores Open Access       Date:  2013-06

9.  Activation of the type I interferon pathway is enhanced in response to human neuronal differentiation.

Authors:  Jocelyn R Farmer; Kate M Altschaefl; K Sue O'Shea; David J Miller
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  Healthy human CSF promotes glial differentiation of hESC-derived neural cells while retaining spontaneous activity in existing neuronal networks.

Authors:  Heikki Kiiski; Riikka Aänismaa; Jyrki Tenhunen; Sanna Hagman; Laura Ylä-Outinen; Antti Aho; Arvi Yli-Hankala; Stepani Bendel; Heli Skottman; Susanna Narkilahti
Journal:  Biol Open       Date:  2013-05-13       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.